Jacoulet P, Maheu M F, Loire R, Saugier B, DePierre A
Department of Respiratory Diseases, Besancon University Hospital, France.
Am J Clin Oncol. 1996 Jun;19(3):260-2. doi: 10.1097/00000421-199606000-00010.
Cure after 8 years of a non-small-cell lung cancer (NSCLC), inoperable because of locoregional spread, is reported. The authors believe this case represents the longest survival after monochemotherapy reported to date and provides the opportunity to review studies of prognostic factors concerning long-term survival in NSCLC.
据报道，一名因局部区域扩散而无法手术的非小细胞肺癌（NSCLC）患者在8年后治愈。作者认为该病例代表了迄今为止报道的单药化疗后最长生存期，并为回顾NSCLC长期生存的预后因素研究提供了机会。
